Status:
RECRUITING
Institution of an Italian Registry and Biobank for Biological Sample Collection
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Lymphatic Malformation
Lymphatic Abnormality
Eligibility:
All Genders
Up to 100 years
Phase:
NA
Brief Summary
Lymphatic malformations (ML), are benign non-neoplastic, rare, resulting from an embryologic abnormal development of the lymphatic system. Sometimes they may be associated with other vascular malforma...
Detailed Description
ENDPOINT Primary endpoint * To estimate the prevalence and incidence of ML in Italy using data derived from the computerized registry created Secondary endpoints * To create a collection of biologica...
Eligibility Criteria
Inclusion
- Age 0-100 years
- Signed informed consent.
- Individuals with any type of ML (isolated, syndromic, congenital or acquired, with or without molecular confirmation) identified by participating centers
Exclusion
- Patients whose clinical picture is not compatible with points a) (b) and (c) of the inclusion criteria, as assessed by the Investigator.
Key Trial Info
Start Date :
June 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 27 2044
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06892964
Start Date
June 27 2024
End Date
June 27 2044
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Woman and Child Health and Public Health, Fondazione Policlinico A. Gemelli, IRCCS
Roma, Italy, 00168